📰Introducing the IACH Case Report Forum Every case has a story. Every story has a lesson. We are delighted to launch the IACH Case Report Forum, a new educational initiative bringing together the global hematology community through real-world clinical cases, expert insights, and interactive discussions. Most episodes will be inspired by cases published in our journal, Clinical Hematology International: Case Reports, bringing these publications to life and transforming individual clinical experiences into shared knowledge. From unusual presentations to diagnostic dilemmas and unexpected treatment outcomes, our goal is to stimulate clinical reasoning and translate real-world experiences into practical learning. Real cases. Real challenges. Expert insights. Global learning. 🎬 Watch our launch announcement and discover what’s coming! ⬇️Visit the CHI: Case Reports Journal chi-cr.scholasticahq.com/ @Mohty_EBMT

🏥 Can bispecific therapy be delivered safely in the outpatient setting? As treatment moves beyond clinical trials and into routine practice, managing CRS, ICANS and infection risk becomes critical. What does safe outpatient administration look like — and how can we minimize treatment interruptions? Join Elena Zamagni for a practical look at delivering bispecifics safely. 📅 December 11, 2026 | 07:00–10:00AM CT 📍 Great Hall A-D | In person + virtual 👉 Register today: ash-symposium.iach.org/#regi… @ElenaZamagni @Mohty_EBMT #MultipleMyeloma #IACH #Hematology

📢𝗪𝗲 𝗮𝗿𝗲 𝗟𝗜𝗩𝗘 𝗧𝗵𝗲 𝗜𝗺𝗽𝗮𝗰𝘁 𝗼𝗳 𝗣𝘀𝘆𝗰𝗵𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗙𝗮𝗰𝘁𝗼𝗿𝘀 𝗼𝗻 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗳𝗼𝗿 𝗠𝘆𝗲𝗹𝗼𝗺𝗮 with William Kenneth Casler Join the webinar → us06web.zoom.us/webinar/regi… @Mohty_EBMT

Happening TODAY! 𝗧𝗵𝗲 𝗜𝗺𝗽𝗮𝗰𝘁 𝗼𝗳 𝗣𝘀𝘆𝗰𝗵𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗙𝗮𝗰𝘁𝗼𝗿𝘀 𝗼𝗻 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗳𝗼𝗿 𝗠𝘆𝗲𝗹𝗼𝗺𝗮 with William Kenneth Casler 6 pm CET • 12 pm NY Register now for free👇 us06web.zoom.us/webinar/regi… @Mohty_EBMT

💡 𝘐𝘈𝘊𝘏 𝘞𝘦𝘣𝘪𝘯𝘢𝘳 𝘐𝘯𝘴𝘪𝘨𝘩𝘵𝘴: 𝘉𝘦𝘺𝘰𝘯𝘥 𝘵𝘩𝘦 𝘞𝘦𝘣𝘪𝘯𝘢𝘳 𝗖𝗘𝗟𝗠𝗼𝗗𝘀 𝗶𝗻 𝗠𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝗠𝘆𝗲𝗹𝗼𝗺𝗮: 𝗔 𝗡𝗲𝘄 𝗘𝗿𝗮 𝗼𝗳 𝗖𝗲𝗿𝗲𝗯𝗹𝗼𝗻 𝗠𝗼𝗱𝘂𝗹𝗮𝘁𝗶𝗼𝗻 🎙️𝘛𝘶𝘯𝘦 𝘪𝘯𝘵𝘰 𝘢 𝘯𝘦𝘸 𝘱𝘰𝘥𝘤𝘢𝘴𝘵: on.soundcloud.com/YsRezVOqgP… 🧑‍💻𝘎𝘢𝘪𝘯 𝘬𝘦𝘺 𝘵𝘢𝘬𝘦𝘢𝘸𝘢𝘺𝘴 𝘧𝘳𝘰𝘮 𝘰𝘶𝘳 𝘐𝘈𝘊𝘏 𝘙𝘰𝘶𝘯𝘥𝘵𝘢𝘣𝘭𝘦 𝘋𝘦𝘣𝘢𝘵𝘦 𝘞𝘦𝘣𝘪𝘯𝘢𝘳: 𝗘𝘃𝗼𝗹𝘃𝗶𝗻𝗴 𝗿𝗼𝗹𝗲 𝗼𝗳 𝗖𝗘𝗟𝗠𝗼𝗗𝘀 𝗶𝗻 𝗺𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝗺𝘆𝗲𝗹𝗼𝗺𝗮 𝘞𝘢𝘵𝘤𝘩 𝘵𝘩𝘦 𝘸𝘦𝘣𝘪𝘯𝘢𝘳 𝘧𝘰𝘳 𝘍𝘙𝘌𝘌🔽 iach.org/iach-special-sessio… @paurotero @Mohty_EBMT @thanosdimop @SagarLonialMD @ThierryFacon @abazarbachi

📢𝗪𝗲 𝗮𝗿𝗲 𝗟𝗜𝗩𝗘 𝗔𝗻𝘁𝗶-𝗖𝗗𝟯𝟴 𝗺𝗔𝗯-𝗯𝗮𝘀𝗲𝗱 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 𝗮𝗰𝗿𝗼𝘀𝘀 𝘁𝗵𝗲 𝗺𝘆𝗲𝗹𝗼𝗺𝗮 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝘂𝗺 with María Victoria Mateos Join the webinar → us06web.zoom.us/webinar/regi…… @Mohty_EBMT @mvmateos

🌍 Clinical trials tell us what bispecifics can do. Real-world evidence tells us what happens in daily practice. How do outcomes compare outside the controlled environment of clinical trials? And what challenges emerge when anti-BCMA bispecifics are integrated into routine care? Join Karthik Ramasamy to explore real-world outcomes and the practical challenges of delivering bispecific therapy. 📅 December 11, 2026 | 07:00–10:00AM CT 📍 Great Hall A-D | In person + virtual 👉 Register today: ash-symposium.iach.org/#regi… @Mohty_EBMT #MultipleMyeloma #IACH

Our latest IACH for Patients Webinar: Using Your Voice for Change: Advocacy, Awareness, and Hope in Blood Cancers with Mags McCarthy Now available on demand! Watch the full webinar for FREE ⬇️ iach.org/patients/ @mags__mccarthy @Mohty_EBMT

👂𝘛𝘶𝘯𝘦 𝘪𝘯 𝘵𝘰 𝘵𝘩𝘦 𝘭𝘢𝘵𝘦𝘴𝘵 𝘐𝘈𝘊𝘏 𝘕𝘦𝘸𝘴 𝘱𝘰𝘥𝘤𝘢𝘴𝘵 𝘦𝘯𝘵𝘪𝘵𝘭𝘦𝘥: 𝗧𝗲𝗰𝗹𝗶𝘀𝘁𝗮𝗺𝗮𝗯 𝗶𝗻 𝗵𝗶𝗴𝗵-𝗿𝗶𝘀𝗸 𝘀𝗺𝗼𝗹𝗱𝗲𝗿𝗶𝗻𝗴 𝗺𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝗺𝘆𝗲𝗹𝗼𝗺𝗮 ⬇️⬇️ on.soundcloud.com/LUPb8KggLC… 𝘊𝘭𝘪𝘤𝘬 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘢𝘣𝘴𝘵𝘳𝘢𝘤𝘵👇 pubmed.ncbi.nlm.nih.gov/4272… @Mohty_EBMT

👂𝘛𝘶𝘯𝘦 𝘪𝘯 𝘵𝘰 𝘵𝘩𝘦 𝘭𝘢𝘵𝘦𝘴𝘵 𝘐𝘈𝘊𝘏 𝘕𝘦𝘸𝘴 𝘱𝘰𝘥𝘤𝘢𝘴𝘵 𝘦𝘯𝘵𝘪𝘵𝘭𝘦𝘥: 𝗔𝗻𝗶𝘁𝗼-𝗰𝗲𝗹, 𝗮 𝗱-𝗗𝗼𝗺𝗮𝗶𝗻 𝗕𝗖𝗠𝗔 𝗖𝗔𝗥 𝗧 𝗖𝗲𝗹𝗹 𝗳𝗼𝗿 𝗥𝗲𝗳𝗿𝗮𝗰𝘁𝗼𝗿𝘆 𝗼𝗿 𝗥𝗲𝗰𝘂𝗿𝗿𝗲𝗻𝘁 𝗠𝘆𝗲𝗹𝗼𝗺𝗮 ⬇️⬇️ on.soundcloud.com/vImnwB4H0a… 𝘊𝘭𝘪𝘤𝘬 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘢𝘣𝘴𝘵𝘳𝘢𝘤𝘵👇 pubmed.ncbi.nlm.nih.gov/4277… @Mohty_EBMT

Join us for the upcoming IACH for Patients 𝗧𝗵𝗲 𝗜𝗺𝗽𝗮𝗰𝘁 𝗼𝗳 𝗣𝘀𝘆𝗰𝗵𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗙𝗮𝗰𝘁𝗼𝗿𝘀 𝗼𝗻 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗳𝗼𝗿 𝗠𝘆𝗲𝗹𝗼𝗺𝗮 with William Kenneth Casler Thursday, October 22 6 pm CET • 12 pm NY Register now for free👇 us06web.zoom.us/webinar/regi… @Mohty_EBMT

👂Hear the latest IACH news in French: Myélome et MRD : de la prédiction à la décision! ⬇️⬇️ on.soundcloud.com/LSnA9ShaZX… @Mohty_EBMT

Happening on Wednesday IACH Multiple Myeloma Masterclass Series: 𝗔𝗻𝘁𝗶-𝗖𝗗𝟯𝟴 𝗺𝗔𝗯-𝗯𝗮𝘀𝗲𝗱 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 𝗮𝗰𝗿𝗼𝘀𝘀 𝘁𝗵𝗲 𝗺𝘆𝗲𝗹𝗼𝗺𝗮 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝘂𝗺 with María Victoria Mateos 6 pm CET • 12 pm NY Register now for free👇 us06web.zoom.us/webinar/regi…… @mvmateos @Mohty_EBMT

Our latest IACH Multiple Myeloma Masterclass: MRD-Guided Treatment Decisions: From Bench to Bedside with Rafael Fonseca Now available on demand! Watch the full webinar for FREE ⬇️ iach.org/iach-expert-masterc… @Rfonsi1 @Mohty_EBMT

🔴 Day 2 of #IACH2026 is here! Another day of expert discussions, emerging evidence, and clinical perspectives from our international faculty. Welcome back to everyone joining us in Paris and online! Join the live broadcast ⬎ bit.ly/4ymk6Yx @Mohty_EBMT #Hematology

Join us for the upcoming IACH Multiple Myeloma Masterclass Series: 𝗔𝗻𝘁𝗶-𝗖𝗗𝟯𝟴 𝗺𝗔𝗯-𝗯𝗮𝘀𝗲𝗱 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 𝗮𝗰𝗿𝗼𝘀𝘀 𝘁𝗵𝗲 𝗺𝘆𝗲𝗹𝗼𝗺𝗮 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝘂𝗺 with María Victoria Mateos Wednesday, October 21 6 pm CET • 12 pm NY Register now for free👇 us06web.zoom.us/webinar/regi… @mvmateos @Mohty_EBMT

🚨𝗪𝗲’𝗿𝗲 𝗸𝗶𝗰𝗸𝗶𝗻𝗴 𝗼𝗳𝗳 𝗗𝗮𝘆 𝟮! 𝘞𝘦’𝘳𝘦 𝘥𝘦𝘭𝘪𝘨𝘩𝘵𝘦𝘥 𝘵𝘰 𝘸𝘦𝘭𝘤𝘰𝘮𝘦 𝘦𝘷𝘦𝘳𝘺𝘰𝘯𝘦 𝘫𝘰𝘪𝘯𝘪𝘯𝘨 𝘶𝘴 𝘰𝘯𝘴𝘪𝘵𝘦 𝘪𝘯 𝘗𝘢𝘳𝘪𝘴 𝘢𝘯𝘥 𝘰𝘯𝘭𝘪𝘯𝘦 𝘧𝘳𝘰𝘮 𝘢𝘳𝘰𝘶𝘯𝘥 𝘵𝘩𝘦 𝘸𝘰𝘳𝘭𝘥. 𝘋𝘰𝘯’𝘵 𝘮𝘪𝘴𝘴 𝘵𝘩𝘦 𝘭𝘪𝘷𝘦 𝘴𝘦𝘴𝘴𝘪𝘰𝘯𝘴 𝘫𝘰𝘪𝘯 𝘵𝘩𝘦 𝘣𝘳𝘰𝘢𝘥𝘤𝘢𝘴𝘵 𝘩𝘦𝘳𝘦 ⬎ bit.ly/4ymk6Yx @Mohty_EBMT